DK1572169T3 - Påvisning og modulering af Slit- og Robo-medieret angiogenese og anvendelser deraf - Google Patents

Påvisning og modulering af Slit- og Robo-medieret angiogenese og anvendelser deraf

Info

Publication number
DK1572169T3
DK1572169T3 DK03716469.6T DK03716469T DK1572169T3 DK 1572169 T3 DK1572169 T3 DK 1572169T3 DK 03716469 T DK03716469 T DK 03716469T DK 1572169 T3 DK1572169 T3 DK 1572169T3
Authority
DK
Denmark
Prior art keywords
robo
slit
modulation
applications
detection
Prior art date
Application number
DK03716469.6T
Other languages
English (en)
Inventor
Jian-Guo Geng
Original Assignee
Shanghai Inst Biol Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Inst Biol Sciences filed Critical Shanghai Inst Biol Sciences
Application granted granted Critical
Publication of DK1572169T3 publication Critical patent/DK1572169T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
DK03716469.6T 2002-03-08 2003-03-10 Påvisning og modulering af Slit- og Robo-medieret angiogenese og anvendelser deraf DK1572169T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36248502P 2002-03-08 2002-03-08
PCT/US2003/007458 WO2003075860A2 (en) 2002-03-08 2003-03-10 Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof

Publications (1)

Publication Number Publication Date
DK1572169T3 true DK1572169T3 (da) 2013-10-21

Family

ID=27805180

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03716469.6T DK1572169T3 (da) 2002-03-08 2003-03-10 Påvisning og modulering af Slit- og Robo-medieret angiogenese og anvendelser deraf

Country Status (8)

Country Link
US (1) US7939497B2 (da)
EP (2) EP1572169B1 (da)
AU (1) AU2003220173A1 (da)
DK (1) DK1572169T3 (da)
ES (1) ES2431040T3 (da)
PT (1) PT1572169E (da)
SI (1) SI1572169T1 (da)
WO (1) WO2003075860A2 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60127986T2 (de) * 2000-11-06 2008-01-17 Cancer Research Technology Ltd. Bildgebende verfahren, diagnose und behandlung von krankheiten
CA2490713A1 (en) * 2002-06-27 2004-01-08 University Of Utah Research Foundation Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis
DK1565491T3 (da) * 2002-11-20 2010-07-19 Cancer Rec Tech Ltd Antistoffer, der binder til human magic roundabout (MR), polypeptider og anvendelser deraf til inhibering af angiogenese
US20060025335A1 (en) * 2004-01-30 2006-02-02 Kinane Thomas B Netrin compositions and methods of using the same
EP1744162B1 (en) * 2004-03-31 2010-08-04 Hiroyuki Aburatani Cancer diagnosis and treatment using anti-robo1 antibody
US8940488B2 (en) 2004-03-31 2015-01-27 Hiroyuki Aburatani Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
CA2672297A1 (en) 2006-12-11 2008-06-19 University Of Utah Research Foundation Compositions and methods for treating pathologic angiogenesis and vascular permeability
CA2676766A1 (en) * 2007-02-09 2008-08-21 Genentech, Inc. Anti-robo4 antibodies and uses therefor
CN101687014A (zh) * 2008-04-16 2010-03-31 犹他大学研究基金会 用于治疗病理性血管生成和血管通透的组合物和方法
AU2010203755A1 (en) * 2009-01-06 2010-07-15 Eli Lilly And Company Random Homozygous Gene Perturbation (RHGP) with thermal asymmetric interlaced (TAIL)-PCR
FR2958936A1 (fr) 2010-04-14 2011-10-21 Sanofi Aventis Proteine de fusion robo1-fc et son utilisation dans le traitement des tumeurs
CN102233134A (zh) * 2010-04-30 2011-11-09 中国科学院上海生命科学研究院 Slit-robo介导的淋巴管形成及其应用
EP2621511A1 (en) * 2010-09-28 2013-08-07 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical compositions for the treatment of bone density related diseases
SG191060A1 (en) 2010-12-23 2013-07-31 Sanofi Sa Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
KR102103323B1 (ko) * 2012-01-05 2020-05-29 보스턴 메디칼 센터 코포레이션 신장 질환의 진단 및 치료를 위한 ｓｌｉｔ­ｒｏｂｏ 신호전달
KR101897322B1 (ko) * 2015-01-21 2018-09-10 재단법인 아산사회복지재단 원발성 갑상선암 전이의 진단방법 및 이를 이용한 진단키트
CN104711279B (zh) * 2015-03-17 2018-03-02 山东一达启航生物科技有限公司 一种血管内皮生长因子检测试剂盒及其原料制备
MX2019014480A (es) 2017-06-02 2020-01-23 Pfizer Proteinas recombinantes robo2, composiciones, metodos y usos de las mismas.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE463851B (sv) 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
DE4221256C2 (de) 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
US5869305A (en) 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
US5629327A (en) 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US5741511A (en) 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction
US5888767A (en) 1996-11-27 1999-03-30 The Johns Hopkins University School Of Medicine Method of using a conditionally replicating viral vector to express a gene
US5941868A (en) 1995-12-22 1999-08-24 Localmed, Inc. Localized intravascular delivery of growth factors for promotion of angiogenesis
US5736154A (en) 1996-03-11 1998-04-07 Fuisz Technologies Ltd. Transdermal delivery system
SE9703226D0 (sv) 1997-09-08 1997-09-08 Astra Ab New pharmaceutical composition
EP1025231B1 (en) * 1997-10-20 2003-07-16 The Regents of the University of California Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance
US6197801B1 (en) 1998-01-14 2001-03-06 Usa Doctors Products, Inc. Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction
US5962274A (en) 1998-03-13 1999-10-05 Wake Forest University Viral vector directed to predetermined target cells
AU3767300A (en) * 1999-03-26 2000-10-16 Human Genome Sciences, Inc. 47 human secreted proteins
US6811788B2 (en) 2000-01-19 2004-11-02 Baofa Yu Combinations and methods for treating neoplasms
DK1565491T3 (da) * 2002-11-20 2010-07-19 Cancer Rec Tech Ltd Antistoffer, der binder til human magic roundabout (MR), polypeptider og anvendelser deraf til inhibering af angiogenese

Also Published As

Publication number Publication date
US7939497B2 (en) 2011-05-10
EP2316853A2 (en) 2011-05-04
PT1572169E (pt) 2013-10-08
AU2003220173A1 (en) 2003-09-22
EP1572169A4 (en) 2007-07-25
ES2431040T3 (es) 2013-11-22
AU2003220173A8 (en) 2003-09-22
WO2003075860A2 (en) 2003-09-18
EP1572169B1 (en) 2013-07-17
SI1572169T1 (sl) 2013-12-31
EP2316853A3 (en) 2011-10-05
WO2003075860A3 (en) 2006-08-17
US20030236210A1 (en) 2003-12-25
EP1572169A2 (en) 2005-09-14

Similar Documents

Publication Publication Date Title
DK1572169T3 (da) Påvisning og modulering af Slit- og Robo-medieret angiogenese og anvendelser deraf
DK1438306T3 (da) Derivater af UK-2A
DK3025726T3 (da) Polyalkylenpolymerforbindelser og anvendelser deraf
IS7344A (is) Stýrð efnasmíði síprasídóns og samsetninga af því
NO20033600L (no) Meget folsomt tverrakseakselerometer
FR2830206B1 (fr) Dispositif microfluidique et sa fabrication
DK1572744T3 (da) Immunoglobulinvarianter og deres anvendelser
DK1578771T3 (da) Remodellering og glycokonjugering af peptider
DK1576132T3 (da) Nukleinsyrer benævnt 273p4b7 og anvendelse heraf til detektering af cancer
DE60135891D1 (de) Verbreitung der Positionsdaten und Positionsentdeckung
DE60238206D1 (de) Frequenz- und amplitudenapodisierung von wandlern
DE602004018489D1 (de) Demodulierung und wiederholungsdecodierung von mehrschichtigen signalen
DE60140791D1 (de) Taktrückgewinnungsschaltung und Empfangsschaltung
DE50204161D1 (de) Doppelseitiges Klebeband
DK1891571T3 (da) Hæmning af spredning af uønskede koder og data
ATE370938T1 (de) Pro-pharmakon von cox-2-inhibitoren
DE60331199D1 (de) Trennung und rückgewinnung von bor
DK1478648T3 (da) Phosphorholdige forbindelser og anvendelser deraf
DK1532474T3 (da) Markering af rørforforbindelser
DE60334592D1 (de) Differentialpumpvorrichtung und Belichtungsgerät
DK1470732T3 (da) Fremskaffelse af lokaliseringsinformation
DK1506171T3 (da) Fremstillinger af et sulfinylacetamid
DE60330269D1 (de) Piperazinyl- und diazapanylbenzamide und-benzothioamide
DE10295497D2 (de) Vernetzung von Photoinitiator-initialisierten Polyacrylaten
IS7783A (is) Flóð og fjöru-ker